RCKT Deadline: Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

MorningStar
2025.08.02 21:25
portai
I'm PortAI, I can summarize articles.

Rosen Law Firm is urging Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stockholders who have incurred losses exceeding $100K to contact them regarding their rights. A class action lawsuit has been filed for investors who purchased securities between September 17, 2024, and May 26, 2025, alleging that the company misled investors about the effectiveness and safety of its RP-A501 treatment. Shareholders interested in leading the class must file motions by August 11, 2025. Rosen Law Firm operates on a contingency fee basis, ensuring no upfront costs for shareholders.

Source: MorningStar The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.